Literature DB >> 25632188

Factors associated with significant liver fibrosis assessed using transient elastography in general population.

Seng Chan You1, Kwang Joon Kim1, Seung Up Kim1, Beom Kyung Kim1, Jun Yong Park1, Do Young Kim1, Sang Hoon Ahn1, Won Jae Lee1, Kwang-Hyub Han1.   

Abstract

AIM: To investigate the prevalence of significant liver fibrosis assessed using transient elastography (TE) and its predictors in asymptomatic general population.
METHODS: A total of 159 subjects without chronic viral hepatitis who underwent comprehensive medical health check-up between January 2012 and July 2012 were prospectively recruited. Significant liver fibrosis was defined as liver stiffness value>7.0 kPa.
RESULTS: The mean age and body mass index (BMI) of the study population (men 54.7%) was 56.0 years and 24.3 kg/m2. Among the study subjects, 11 (6.9%) showed significant liver fibrosis. On univariate analysis, BMI, alanine aminotransferase (ALT), homeostasis model assessment of insulin resistance, carotid intimal media thickness (IMT), number of calcified plaques on carotid ultrasound, and visceral fat area on computed tomography were significantly higher in subjects with significant liver fibrosis than in those without (all P<0.05). However, on multivariate analysis, BMI [odds ratio (OR)=.487; P=0.045], ALT (OR=1.078; P=0.014), carotid IMT (OR=3.244; P=0.027), and the number of calcified carotid plaques (OR=1.787; P=0.031) were independent predictors of significant liver fibrosis.
CONCLUSION: The prevalence of significant liver fibrosis assessed using TE was 6.9% in apparently healthy subjects. High BMI, high ALT, thicker carotid IMT, and higher numbers of calcified carotid plaques were independently associated with the presence of significant liver fibrosis.

Entities:  

Keywords:  Alanine aminotransferase; Body mass index; Carotid artery plaque; Carotid intimal medial thickness; Fibroscan; Healthy subjects; Liver fibrosis; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Transient elastography

Mesh:

Year:  2015        PMID: 25632188      PMCID: PMC4306159          DOI: 10.3748/wjg.v21.i4.1158

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

Review 1.  Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  J Hepatol       Date:  2008-07-02       Impact factor: 25.083

2.  "Normal" range of alanine aminotransferase levels for Asian population.

Authors:  Beom Kyung Kim; Kwang-Hyun Han; Sang Hoon Ahn
Journal:  J Gastroenterol Hepatol       Date:  2011-02       Impact factor: 4.029

3.  Metabolic parameters and nonalcoholic fatty liver disease in hypopituitary men.

Authors:  J W Hong; J Y Kim; Y-E Kim; E J Lee
Journal:  Horm Metab Res       Date:  2010-09-23       Impact factor: 2.936

4.  Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

Authors:  Cecilia Söderberg; Per Stål; Johan Askling; Hans Glaumann; Greger Lindberg; Joel Marmur; Rolf Hultcrantz
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

5.  Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis.

Authors:  Seung Up Kim; Sang Hoon Ahn; Jun Yong Park; Wonseok Kang; Do Young Kim; Young Nyun Park; Chae Yoon Chon; Kwang Hyub Han
Journal:  J Clin Gastroenterol       Date:  2009-03       Impact factor: 3.062

6.  Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease.

Authors:  Pierre Nahon; Adrien Kettaneh; Iulia Tengher-Barna; Marianne Ziol; Victor de Lédinghen; Catherine Douvin; Patrick Marcellin; Nathalie Ganne-Carrié; Jean-Claude Trinchet; Michel Beaugrand
Journal:  J Hepatol       Date:  2008-10-07       Impact factor: 25.083

7.  Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome.

Authors:  Dominique Roulot; Sébastien Czernichow; Hervé Le Clésiau; Jean-Luc Costes; Anne-Claire Vergnaud; Michel Beaugrand
Journal:  J Hepatol       Date:  2008-01-03       Impact factor: 25.083

8.  Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Noreen Hossain; Arian Afendy; Maria Stepanova; Fatema Nader; Manirath Srishord; Nila Rafiq; Zachary Goodman; Zobair Younossi
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-25       Impact factor: 11.382

9.  Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease.

Authors:  Vincent Wai-Sun Wong; Julien Vergniol; Grace Lai-Hung Wong; Juliette Foucher; Henry Lik-Yuen Chan; Brigitte Le Bail; Paul Cheung-Lung Choi; Mathurin Kowo; Anthony Wing-Hung Chan; Wassil Merrouche; Joseph Jao-Yiu Sung; Victor de Lédinghen
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

10.  Metabolic syndrome and carotid artery parameter in Koreans aged 50 years and older.

Authors:  Young-Hoon Lee; Min-Ho Shin; Sun-Seog Kweon; Jung-Ae Rhee; So-Yeon Ryu; Hye-Ran Ahn; Jin-Su Choi
Journal:  Circ J       Date:  2010-01-26       Impact factor: 2.993

View more
  19 in total

1.  Risk Assessment of Hepatocellular Carcinoma in General Population by Liver Stiffness in Combination with Controlled Attenuation Parameter using Transient Elastography: A Cross Sectional Study.

Authors:  Takaaki Sugihara; Masahiko Koda; Tomomitsu Matono; Kinya Okamoto; Yoshikazu Murawaki; Hajime Isomoto; Shiho Tokunaga
Journal:  Yonago Acta Med       Date:  2017-06-26       Impact factor: 1.641

2.  Sex Differences, Cocaine Use, and Liver Fibrosis Among African Americans in the Miami Adult Studies on HIV Cohort.

Authors:  Gustavo Zarini; Sabrina Sales Martinez; Adriana Campa; Kenneth Sherman; Javier Tamargo; Jacqueline Hernandez Boyer; Colby Teeman; Angelique Johnson; Abraham Degarege; Pedro Greer; Qingyun Liu; Yongjun Huang; Raul Mandler; David Choi; Marianna K Baum
Journal:  J Womens Health (Larchmt)       Date:  2020-01-31       Impact factor: 2.681

Review 3.  The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View.

Authors:  Christina C Lindenmeyer; Arthur J McCullough
Journal:  Clin Liver Dis       Date:  2018-02       Impact factor: 6.126

4.  Prevalence and Prognostic Significance of Liver Fibrosis in Patients With Aneurysmal Subarachnoid Hemorrhage.

Authors:  Tiangui Li; Peng Wang; Xiao Gong; Weelic Chong; Yang Hai; Chao You; Juan Kang; Fang Fang; Yu Zhang
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

5.  Liver Fibrosis is Associated with Ischemic Stroke Risk in Women but not Men: The REGARDS Study.

Authors:  Neal S Parikh; Insu Koh; Lisa B VanWagner; Mitchell S V Elkind; Neil A Zakai; Mary Cushman
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-04-16       Impact factor: 2.677

6.  The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program.

Authors:  Pin-Nan Cheng; Yen-Cheng Chiu; Hung-Chih Chiu; Shih-Chieh Chien
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus.

Authors:  Ja Yoon Heo; Seung Up Kim; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Young Nyun Park; Sung Soo Ahn; Kwang-Hyub Han; Hyon-Suk Kim
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

8.  Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.

Authors:  Gyuri Kim; Kwang Joon Kim; Yumie Rhee; Sung-Kil Lim
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

9.  Liver Fibrosis Indices and Outcomes After Primary Intracerebral Hemorrhage.

Authors:  Neal S Parikh; Hooman Kamel; Babak B Navi; Costantino Iadecola; Alexander E Merkler; Arun Jesudian; Jesse Dawson; Guido J Falcone; Kevin N Sheth; David J Roh; Mitchell S V Elkind; Daniel F Hanley; Wendy C Ziai; Santosh B Murthy
Journal:  Stroke       Date:  2020-01-07       Impact factor: 7.914

10.  The XL probe: A luxury or a necessity? Risk stratification in an obese community cohort using transient elastography.

Authors:  Rebecca Harris; Timothy R Card; Toby Delahooke; Guruprasad P Aithal; I Neil Guha
Journal:  United European Gastroenterol J       Date:  2018-04-18       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.